Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) EV to EBIT (2021 - 2023)

Updated

Moderna's (MRNA) EV to EBIT stood at 73.75 in Q2 2023, compared with 3.08 a year earlier and up 611.2% from the prior quarter.

Analysis

Moderna (MRNA) EV to EBIT (2021 - 2023) Analysis & Trends

On a TTM basis, Moderna's EV to EBIT came in at 20.78 as of Jun 30, 2023; for FY2022, it was 6.29, down 8.7% from FY2021.

  • Across earlier years, EV to EBIT came in at 6.89 in FY2021.
  • The Q2 2023 figure is the highest quarterly EV to EBIT in data going back to Q1 2021.
  • On a year-over-year basis, EV to EBIT rose in 1 of the last five quarters, with an average decline of 17.7%.
  • Per Business Quant, the preceding three quarters came in at 10.37 (Q1 2023), 6.29 (Q4 2022) and 2.82 (Q3 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 73.75
Mar 31, 2023 10.37
Dec 31, 2022 6.29
Sep 30, 2022 2.82
Jun 30, 2022 3.08
Mar 31, 2022 3.62
Dec 31, 2021 6.89
Sep 30, 2021 19.31
Jun 30, 2021 22.71
Mar 31, 2021 70.62
API Access

Moderna EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=MRNA&period=max&api_key=YOUR_API_KEY